Laurus Labs Limited (NSE:LAURUSLABS)
India · Delayed Price · Currency is INR 849.35
-25.00 (-2.86%)
Aug 1, 2025, 3:30 PM IST
Revance Therapeutics Market Cap
Laurus Labs has a market cap or net worth of 458.50 billion as of August 1, 2025. Its market cap has increased by 82.86% in one year.
Market Cap
458.50B
Enterprise Value
486.00B
Revenue
59.29B
Ranking
n/a
PE Ratio
89.90
Stock Price
$849.35
Market Cap Chart
Since December 19, 2016, Laurus Labs's market cap has increased from 47.44B to 458.50B, an increase of 866.53%. That is a compound annual growth rate of 30.10%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 1, 2025 | 458.50B | 41.07% |
| Dec 31, 2024 | 325.01B | 40.17% |
| Dec 29, 2023 | 231.86B | 14.74% |
| Dec 30, 2022 | 202.07B | -30.12% |
| Dec 31, 2021 | 289.18B | 52.60% |
| Dec 31, 2020 | 189.50B | 392.69% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 19, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sun Pharmaceutical Industries | 4,159.97B |
| Divi's Laboratories | 1,765.37B |
| Cipla | 1,259.61B |
| Apollo Hospitals Enterprise | 1,071.20B |
| Mankind Pharma | 1,062.98B |
| Zydus Lifesciences | 1,001.35B |
| Aurobindo Pharma | 672.57B |
| Fortis Healthcare | 636.20B |